Background. The unprecedented reemergence of Zika virus (ZIKV) has startled the world with reports of increased microcephaly in Brazil. ZIKV can infect human neural progenitors and impair brain growth. However, direct evidence of ZIKV infection in human fetal brain tissues remains elusive.
Zika virus (ZIKV) is an arthropod-borne flavivirus first isolated in Uganda in 1947 that causes Zika virus disease [1] . The disease is generally self-limiting in humans, with a high prevalence of asymptomatic infections of up to 80%. Febrile patients typically experience fever, maculopapular rash, arthralgia conjunctivitis, and headache [2] . ZIKV infections in humans were sporadic and remained neglected over the last 5 decades until the virus reemerged in Micronesia in 2007 [3] and in the French Polynesian islands in 2013 [2, 4] . Outbreaks of ZIKV have occurred in South and Central America since 2014 [5] , and by late 2015, cases of ZIKV infection in Brazil have hit pandemic levels. Currently, there is an estimate of >1.5 million cases in Brazil, with local transmission of ZIKV in >62 countries and territories [6] . Alarmingly, reports indicated a concurrent increase in the number of GuillainBarré syndrome cases in adult patients in French Polynesia [7] and incidences of microcephaly in Brazil [8] , implying a strong association between ZIKV and these neurological disorders. By early 2016, the World Health Organization declared ZIKV as a Public Health Emergency of International Concern. As of 22 September 2016, ZIKV has now expanded globally to countries in Southeast Asia, including Malaysia and Singapore [9] .
Recent evidence has indicated a causal relationship between prenatal ZIKV infection and serious brain anomalies including microcephaly [10] . ZIKV was detected in the brain of a microcephalic fetus [11] . ZIKV infection was demonstrated in neural cells isolated from primary tissue [12] and in human induced pluripotent stem cell-derived neural progenitor cells [13] . ZIKV infection was also reported to attenuate growth of neurosphere and brain organoids [14] through a Toll-like receptor 3-mediated mechanism [15] . Infection in susceptible mouse strains has shown that ZIKV induced brain pathologies in the developing fetus [16, 17] . However, it is still unclear if these models truly reflect the involvement of the different brain cell types during fetal brain development and infection and, in particular, cells of hematopoietic origin such as microglia.
METHODS

Study Approval
Human fetal brain tissue samples from clinically indicated termination of pregnancies at second trimester gestations were collected with full ethical approval granted by the Centralised Institutional Research Board (CIRB: 2013/837/D) of Singapore Health Services. Women gave separate written informed consent for use of discarded tissues for research. Blood samples were collected from healthy donors with written consent in accordance with guidelines from the Health Sciences Authority of Singapore (study approval number: NUS IRB: 10-250). Viruses ZIKV (GenBank accession number KJ776791) used in this study was originally isolated from the French Polynesia outbreak in 2013 [18] . Virus propagation involved multiple passages in Vero-E6 cells (ATCC CRL-1587) and viruses were precleared by centrifugation before storing at −80°C. Vero-E6 cells were regularly tested to be free from mycoplasma contamination. Virus titer was determined using standard plaque assays with Vero-E6 cells. Vero-E6 cells were seeded in 6-well plates and infected with 500 μL of serially diluted ZIKV stocks for 2 hours with intermittent rocking. Thereafter, 3 mL of medium containing 1:1 mixture of 2X Minimum Essential Medium (Sigma-Aldrich), 4% (vol/vol) Agarose (Promega) solution supplemented with 5% (vol/vol) fetal bovine serum (FBS; HyClone) was laid over the cells. Cells were then incubated for 6 days at 37°C. Cells were fixed with 10% formalin in phosphate-buffered saline (PBS; Sigma-Aldrich) before being stained with crystal violet (Sigma-Aldrich) solution for plaque quantification. Vero-E6 cells are grown and passaged in Dulbecco's Modified Eagle Medium (HyClone) supplemented with 10% (vol/vol) FBS.
M A J O R A R T I C L E
Brain Cell Preparations
Meninges were surgically removed from each brain and the excised fetal brain was digested with collagenase type IV (Sigma-Aldrich) for 30 minutes before being further homogenized using a syringe and needle (18G × 1.5 inch; Becton Dickinson). The preparation was then deposited on a 2-layer (40%/80%) Percoll gradient (GE Healthcare) to remove debris and myelin from the brain. Enriched brain cells containing microglia were collected at the intersection between the 40% and 80% layers [19] [20] [21] . Cells were washed in PBS before ZIKV infections were performed as described below. Due to the limited and scarce number of fetal brain cells obtained from each donor, the samples were used and analyzed differently with regard to the various experimental readouts (quantitative reverse-transcription polymerase chain reaction [qRT-PCR] and fluorescence-activated cell sorting [FACS]) described below.
Isolation of Monocytes and Monocyte-Derived Macrophages
Fresh human peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by gradient centrifugation using Ficoll-Paque (GE Healthcare). Untouched monocytes were isolated using an indirect magnetic labeling system (Monocyte Isolation Kit II, Miltenyi Biotec). To differentiate into monocyte-derived macrophages (MDMs), monocytes were plated in complete Iscove Modified Dulbecco's Medium (IMDM) (HyClone) supplemented with 10% (vol/vol) heat-inactivated human serum (HS; Sigma-Aldrich), which was replaced every 2 days. ZIKV infections were performed on monocytes and MDMs (5 days later) as described below.
Virus Infection
ZIKV infections were performed at multiplicity of infection of 10. Each infection mix consisted of virus suspension prepared in serum-free IMDM. Fetal brain cells were incubated with the infection mix at 37°C and allowed to adsorb for 2 hours with intermittent shaking before virus inoculum was removed and replaced with complete IMDM supplemented with 10% (vol/ vol) HS (Sigma-Aldrich). Cells were incubated at 37°C until harvest at 72 hours postinfection (hpi) [16] . Controls were performed with cells undergoing the same infection condition in the absence of infectious ZIKV particles. These controls are referred to as mock-infected samples.
Viral RNA Extraction and Viral Load Analysis
Viral RNA was extracted using QIAamp Viral RNA Mini Kit (Qiagen) according to the manufacturer's instructions. Quantification of ZIKV nonstructural protein (NS) 5 RNA was determined according to qRT-PCR TaqMan assay [22] using QuantiTect Probe RT-PCR Kit (Qiagen) in 12.5-µL reaction volume. All reactions were performed using 7900HT Fast RealTime PCR System machine (Applied Biosciences).
Flow Cytometry and Antibodies
Detection of ZIKV Ag was carried out in a 2-step indirect intracellular labeling process. In brief, cells were fixed with 1× FACS lysing solution (BD Biosciences) and permeabilized in 1× FACS permeabilization solution 2 (BD Biosciences) before staining with a flavivirus-specific mouse monoclonal antibody (clone 4G2) (Millipore) followed by secondary staining with AF488-conjugated goat antimouse immunoglobulin G F(ab') 2 Ab (Invitrogen). Cells were then stained for surface marker CD45 and CX3C chemokine receptor 1 (CX3CR1) PE-Cy7-conjugated mouse antihuman CD45 antibodies (eBioscience) and APC-conjugated mouse antihuman CX3CR1 antibodies (Biolegend). (EGF), fibroblast growth factor 2 (FGF-2), eotaxin, granulocyte colony-stimulating factor (G-CSF), tumor necrosis factor alpha (TNF-α), FMS-like tyrosine kinase 3 ligand (FLT3L), granulocyte-macrophage colony-stimulating factor (GM-CSF), fractalkine, interferon alpha 2 (IFN-α2), interferon gamma (IFN-γ), growth-regulated oncogene (GRO), interleukin 10 (IL-10), monocyte chemotactic protein 3 (MCP-3), interleukin 12 p40 (IL-12p40), macrophage-derived chemokine (MDC), interleukin 12 p70 (IL-12p70), interleukin 13 (IL-13), interleukin 15 (IL-15), soluble CD40 ligand (sCD40L), interleukin 17 alpha (IL-17α), interleukin 1 receptor alpha (IL-1Rα), interleukin 1 alpha (IL-1α), interleukin 9 (IL-9), interleukin 1 beta (IL-1β), interleukin 2 (IL-2), interleukin 3 (IL-3), interleukin 4 (IL-4), interleukin (IL-5), interleukin 6 (IL-6), interleukin 7 (IL-7), interleukin 8 (IL-8), IFN-γ-inducible protein 10 (IP-10), monocyte chemotactic protein 1 (MCP-1), macrophage inhibitory protein 1 alpha (MIP-1α), macrophage inhibitory protein 1 beta (MIP-1β), vascular endothelial growth factor alpha (VEGF-α), platelet-derived growth factor AA (PDGF-αα), platelet-derived growth factor AB/BB (PDGF-αβ/ββ), regulated on activation, normal T cells expressed and secreted (RANTES), and transforming growth factor beta (TGF-β). Preparation of samples, reagents, and immunoassay procedures were performed according to manufacturers' instructions. Data were acquired using Luminex FlexMap 3D instrument (Millipore) and analyzed using Bio-plex Manager 6.0 software (Bio-Rad) based on standard curves plotted through a 5-parameter logistic curve setting. Levels of G-CSF, FLT3L, fractalkine, MDC, IL-13, IL-15, sCD40L, IL-2, IL-4, IL-5, IL-7, IL-12p40, PDGF-αβ/ββ, and VEGF-α were below the detection limit and excluded for further analysis. For the correlation network analysis, a network was constructed using Cytoscape [25] where an edge linking a pair of nodes represented analytes with a pairwise correlation r 2 value >0.8 to consider both positive and negative associations. Only 18 nodes (16 analytes and 2 ZIKV infection parameters) through 34 edges denoting correlations were derived from the initial 465 pairwise comparisons. Hierarchical clustering was done using TM4-MeV [26] .
Statistical Analysis
All statistical analyzes were performed using GraphPad Prism 6. Analyzes between mock and ZIKV-infected groups were performed using nonparametric Mann-Whitney U test (2-tailed) assuming equal variance. A P value <.05 is considered to be statistically significant.
RESULTS
ZIKV Infection in Primary Human Fetal Brain Cells
To determine whether microglial cells from human fetal brains are the targets of ZIKV infection, hematopoietic cells were first obtained from dissociated brain tissues after Percoll-gradient enrichment. Brain cell preparations from 9 different donors (between 14 and 24 gestational weeks) were obtained from terminated pregnancies and infected with the ZIKV H/PF/2013 strain [18] . Analyses of the virus infection in the whole brain cell mix by flow cytometry ( Figure 1A ) and qRT-PCR in paired donor samples showed that the extent of in vitro ZIKV infection varied widely between donors ( Figure 1B and 1C) .
Further analysis in 7 donors revealed that ZIKV antigens were detected largely in CD45 + hematopoietic cells ( Figure 1D and 1F), and not in the CD45 -population ( Figure 1D and 1E).
Importantly, gestational age of the donor fetal samples did not correlate with the level of ZIKV infection (Spearman r coefficient = -0.1198; P = .7606) and viral load (Spearman r coefficient = 0.3866; P = .3085). Further in-depth investigations carried out within the CD45 + cells revealed that microglia, defined by CD45 intermediate and CX3CR1 high [19, 23, 24] expression, were infected with ZIKV ( Figure 1G and 1H) . Given that microglia, the brain resident macrophages, can be infected by ZIKV, an attempt to investigate the susceptibility of peripheral phagocytic cells to ZIKV infection was conducted. Results showed that both monocytes and MDMs had high levels of ZIKV antigen detected at 72 hpi (Figure 2A and 2B ).
Immune Profiling of ZIKV-Infected Fetal Brain Cells
Microglial cells are involved in inflammatory and immune response in the central nervous system [27] . Due to the small number of cells (<1.5 million on average) obtained from the various donors, the levels of 40 immune mediators produced were determined on whole fetal brain cell preparations from both mock-and ZIKV-infected samples at 72 hpi (Figure 3) . Although the response was heterogeneous, ZIKV infection induced a clear antiviral immune response as indicated by the induction of IFN-α ( Figure 3A and 3B) . High levels of proinflammatory immune mediators typically found during neuroinflammation such as IL-6, MIP-1α, MIP-1β, MCP-1, TNF-α, IL-1Rα, IL-1α, IL-1β, IL-8, and IL-12p70 were also detected ( Figure 3B) . Notably, strong correlations were observed between 15 expressed immune mediators with viral load and ZIKV infectivity in microglia ( Figure 3C ).
DISCUSSION
The high variability in ZIKV infection among the donors could be a true reflection of what is seen clinically, where the prevalence of microcephaly is approximately 12.8% of ZIKV-infected Brazilian pregnant women [28] . An association between gestational age and ZIKV infectivity in the donors was not observed. Thus, the difference in virus infectivity could be due to the variation in the efficiency of antiviral response in different people [29] , where ZIKV infection in microglia would induce high levels of inflammation that could be detrimental to the fetus.
Recent reports have shown that placental macrophages such as the Hofbauer cells could be infected with ZIKV [30] , resulting in virus dissemination via the cord blood to the fetus [30] . Notably, ZIKV infection in human PBMCs demonstrated that monocytes and MDMs were highly infected (Figure 2A and  2B) . Likewise, positive ZIKV infection was observed in CD45 high cells ( Figure 1D and 1F) , which are likely leukocytes from the circulatory system. This is a limitation because complete perfusion of human fetal brain samples will remain as a technical challenge to remove traces of peripheral blood. Importantly, reports have also indicated that ZIKV antigens were detected in first-trimester placenta tissues [31] . Therefore, it is plausible that peripheral blood monocytes/ macrophages could serve as a Trojan horse. Once the virus has entered the fetus, it may reach the developing brain through the blood-brain barrier.
Our data suggest that microglia, which are in close contact with blood vessels through their processes [32] , are highly susceptible to ZIKV infection. Infection will lead to the activation of microglia as shown by our in vitro data and by histology in a microcephalic case [11] . This in turn causes local neuroinflammation and, together with virus dissemination into the brain parenchyma, may result in cell death of developing neurons, in particular in the cortex, and lead to neurological alterations and microcephaly. These findings uncover an important role for microglia in the pathogenesis of congenital ZIKV infection, and call for comprehensive studies to decipher the molecular mechanisms involved that will enable targeted therapeutic interventions.
Notes
